An inverse relationship between magnesium intake and diabetes incidence has been observed in a 20-year study published in late August in the journal Diabetes Care.
An inverse relationship between magnesium intake and diabetes incidence has been observed in a 20-year study published in late August in the journal Diabetes Care.
Led by researchers at the University of North Carolina at Chapel Hill, the study pulled 4497 men and women 18 to 30 years old with no diabetes history at baseline. Researchers assessed incidence of patient magnesium intake in relation to incidence of diabetes, insulin resistance, and biomarkers for inflammation, including C-reactive protein, interleukin-6, and fibrinogen.
Over 20 years of follow-up, 330 diabetes cases were recorded.
“People with the highest magnesium intake, who averaged about 200 milligrams of magnesium for every 1,000 calories they consumed, were 47% less likely to have developed diabetes during follow up than those with the lowest intakes, who consumed about 100 milligrams of magnesium per 1,000 calories,” reported Reuters Health.
Regarding the other biomarkers observed, “Consistently, magnesium intake was inversely associated with [CRP, interleukin-6, fibrinogen, and insulin resistance],” wrote the study’s author.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.